Journal of Bioethical Inquiry

, Volume 7, Issue 1, pp 13–29

From Evidence-based Medicine to Marketing-based Medicine: Evidence from Internal Industry Documents

Authors

    • Department of PsychologyMetropolitan State University
  • Peter I. Parry
    • Department of PsychiatryFlinders University
Article

DOI: 10.1007/s11673-010-9208-8

Cite this article as:
Spielmans, G.I. & Parry, P.I. Bioethical Inquiry (2010) 7: 13. doi:10.1007/s11673-010-9208-8

Abstract

While much excitement has been generated surrounding evidence-based medicine, internal documents from the pharmaceutical industry suggest that the publicly available evidence base may not accurately represent the underlying data regarding its products. The industry and its associated medical communication firms state that publications in the medical literature primarily serve marketing interests. Suppression and spinning of negative data and ghostwriting have emerged as tools to help manage medical journal publications to best suit product sales, while disease mongering and market segmentation of physicians are also used to efficiently maximize profits. We propose that while evidence-based medicine is a noble ideal, marketing-based medicine is the current reality.

Keywords

Evidence-based medicine Marketing Marketing-based medicine Pharmaceutical industry Olanzapine Quetiapine

Copyright information

© Springer Science+Business Media B.V. 2010